KRAS Mutation Detection in Paired Frozen and Formalin-Fixed Paraffin-Embedded (FFPE) Colorectal Cancer Tissues

KRAS mutation has been unambiguously identified as a marker of resistance to cetuximab-based treatment in metastatic colorectal cancer (mCRC) patients. However, most studies of KRAS mutation analysis have been performed using homogenously archived CRC specimens, and studies that compare freshly froz...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Solassol, Jérome, Ramos, Jeanne, Crapez, Evelyne, Saifi, Majda, Mangé, Alain, Vianès, Evelyne, Lamy, Pierre-Jean, Costes, Valérie, Maudelonde, Thierry
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Molecular Diversity Preservation International (MDPI) 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3116185/
https://ncbi.nlm.nih.gov/pubmed/21686179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms12053191
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller